OverviewSuggest Edit

Clinigen Group is a rapidly-growing specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time to improve the quality of people’s lives around the world. The Group consists of four synergistic businesses that provide medicines to patients with unmet need through clinical trials, licensed and unlicensed routes: Clinigen Clinical Trial Services (CTS) - The global leader in the specialist supply and management of quality-assured comparator drugs and other commercial medicines for patients in clinical trials. Cinigen is also the leading global patient access specialist working to provide ethical and compliant access to unlicensed medicines for healthcare providers and their patients with high unmet medical need: Idis Managed Access (MA) - Ethically manages early access to unlicensed investigational medicines on behalf of pharmaceutical and biotech companies. Idis Global Access (GA) - Enables access to post-approved medicines in regions where they are not commercially available but where there is a patient need. Clinigen Specialty Pharmaceuticals (SP) - Revitalizes essential hospital only medicines ensuring continuity of supply to hospital pharmacists, doctors and patients.
TypePublic
Founded2010
HQBurton upon Trent, GB
Websiteclinigengroup.com
Employee Ratings2.8

Locations

Clinigen Group is headquartered in
Burton upon Trent, United Kingdom

Location Map

Latest Updates

Employees (est.) (Dec 2019)1,133(+42%)
Revenue (FY, 2019)£456.9 M(+35%)
Share Price (Sept 2020)£6.6 (-2%)
Cybersecurity ratingBMore

Key People/Management at Clinigen Group

Peter Allen

Peter Allen

Independent Non-Executive Chairman
Ian Nicholson

Ian Nicholson

Independent Non-Executive Director
Shaun Chilton

Shaun Chilton

Chief Executive Officer
Anne Hyland

Anne Hyland

Independent Non-Executive Director
Nick Keher

Nick Keher

Chief Financial Officer
Alan Boyd

Alan Boyd

Non-Executive Director
Show more

Clinigen Group Office Locations

Clinigen Group has offices in Burton upon Trent, Hobson, London, Weybridge and in 6 other locations
Burton upon Trent, GB (HQ)
Bermuda House Crown Square, Pitcairn House, First Ave
Hobson, GB
Hobson Industrial Estate
London, GB
25 Bedford Square, Bloomsbury
Weybridge, GB
Idis House, Churchfield Rd
Warriewood, AU
5 Apollo St
Chuo City, JP
3 Chome-6 Nihonbashi
Show all (10)

Clinigen Group Financials and Metrics

Clinigen Group Revenue

Embed Graph
View revenue for all periods
Clinigen Group's revenue was reported to be £456.90 m in FY, 2019
GBP

Revenue (FY, 2019)

456.9m

Gross profit (FY, 2019)

182.3m

Gross profit margin (FY, 2019), %

39.9%

Net income (FY, 2019)

5.2m

EBIT (FY, 2019)

24.4m

Market capitalization (15-Sept-2020)

876.5m

Closing stock price (15-Sept-2020)

6.6

Cash (30-Jun-2019)

83.5m

EV

1.1b
Clinigen Group's current market capitalization is £876.5 m.
GBPFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

339.9m302.3m339.6m456.9m

Revenue growth, %

84%(11%)12%

Cost of goods sold

243.8m179.6m216.1m274.6m

Gross profit

96.1m122.7m123.6m182.3m
GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

1.0m2.2m10.0m5.2m11.3m21.8m27.8m27.8m24.8m32.3m83.5m

Accounts Receivable

692.4k551.4k2.3m4.4m10.8m20.2m51.4m57.6m49.7m65.2m73.2m

Inventories

4.3k60.1k900.0k2.8m3.2m2.5m11.1m15.6m14.9m19.0m35.4m

Current Assets

1.7m3.7m14.8m22.6m37.1m51.4m110.0m112.2m99.3m136.8m231.3m
GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

328.8k156.4k4.3m6.6m11.3m16.2m5.7m13.5m3.8m24.4m

Cash From Operating Activities

997.4k9.1m12.6m4.0m18.3m19.3m13.1m42.1m41.1m42.4m

Dividends Paid

781.0k495.0k2.5m2.6m4.1m4.9m5.6m

Cash From Financing Activities

(846.0k)(4.5m)6.5m13.8m181.3m(12.3m)(33.7m)75.2m
GBPFY, 2009

Financial Leverage

5.7 x
Show all financial metrics

Clinigen Group Operating Metrics

Clinigen Group's Units Shipped was reported to be 4 m in FY, 2016.
FY, 2016

Countries

43

Units Shipped

3.97 m
Show all operating metrics

Clinigen Group Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

Clinigen Group Revenue Breakdown

Embed Graph

Clinigen Group revenue breakdown by business segment: 40.6% from Clinical Trial Services, 29.7% from Managed Access, 11.7% from Global Access, 10.9% from Specialty Pharmaceuticals and 7.2% from Link Healthcare

Clinigen Group Online and Social Media Presence

Embed Graph

Clinigen Group Frequently Asked Questions

  • When was Clinigen Group founded?

    Clinigen Group was founded in 2010.

  • Who are Clinigen Group key executives?

    Clinigen Group's key executives are Peter Allen, Ian Nicholson and Shaun Chilton.

  • How many employees does Clinigen Group have?

    Clinigen Group has 1,133 employees.

  • What is Clinigen Group revenue?

    Latest Clinigen Group annual revenue is £456.9 m.

  • What is Clinigen Group revenue per employee?

    Latest Clinigen Group revenue per employee is £403.3 k.

  • Who are Clinigen Group competitors?

    Competitors of Clinigen Group include ObsEva, Avid Bioservices and Antidote.

  • Where is Clinigen Group headquarters?

    Clinigen Group headquarters is located at Bermuda House Crown Square, Pitcairn House, First Ave, Burton upon Trent.

  • Where are Clinigen Group offices?

    Clinigen Group has offices in Burton upon Trent, Hobson, London, Weybridge and in 6 other locations.

  • How many offices does Clinigen Group have?

    Clinigen Group has 10 offices.